Social Media Ideas for Precision Medicine

<![CDATA[The Future of Precision Medicine Depends on More Than Biology]]>

AI Learns to Predict Patient Outcomes Even When Key Omics Data Are Missing

Precision medicine has long promised a future in which a patient’s treatment is tailored to the molecular signatures written into their genome, transcriptome, epigenome, proteome a...

Precision Medicine Transformed Oncology —It’s Time to Do the Same for Sepsis

It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable.  The post Precision Medicine Transformed...

Machine Learning Reveals Three Diabetes Patient Types Shaping Heart and Kidney Drug Choices

A real-world study of 9000 patients with type 2 diabetes in China used cluster analysis to identify three clinical phenotypes linked to distinct prescribing patterns of heart- and...

Personalized medicine comes to cancer immunotherapy

A phase III trial for personalized melanoma vaccination foreshadows a new era of cancer treatment The post Personalized medicine comes to cancer immunotherapy appeared first on Pe...

Precision for All: Closing the gap between innovation and impact

Why diagnostic-driven therapies need a new commercialization model to reach more eligible patients.

Precure Selects Helix as Multiomics Lab and AI Tools Provider

Mayo Clinic recently launched Precure with founding partner Thermo Fisher Scientific to help transform how the life sciences community understands the biological changes that occur...

Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to Therapeutic Possibilities

Researchers analyzed mulitomic and clinical data from 2000 colorectal cancer samples and used an AI tool, iPhenMap, to help identify cancer cell vulnerabilities and drug combinatio...

Personalized medicine breakthrough for childhood leukemia

Researchers from Newcastle University and Great Ormond Street Hospital have identified new predictors of relapse in children and young people with acute lymphoblastic leukemia (ALL...

Personalised medicine breakthrough for childhood leukaemia

Children with the most common form of childhood cancer could benefit from more personalised treatment thanks to new research that is changing how doctors assess the risk of the dis...

The Epitranscriptome Heads Toward Clinical Necessity

Short-read RNA sequencing reporting the modifications that alter protein output is starting to make epitranscriptomics indispensable for patient selection in precision medicines. T...

Startup Arboretum Sprouts, Bringing a Precision Medicine Approach to Common Diseases

Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say analyses of data from its genetic tests both form the bas...

<![CDATA[Finding the Few: Combining Clinical Insight, Data and Media to Reach Patients with Rare Diseases]]>

Models for personalised Dosing?

You and I both know that the one size fits all dosing suits Pharma and the Neuros because you all get the same amount of drug at the same time and it is easy to work out…No mistake...

How DNA Testing May Help Explain Unexpected Reactions to Certain Medications

Most people expect a new prescription to work the way their doctor described. Sometimes it does, and sometimes it does something else. A pill that settles one person may leave anot...

Probably Genetic raises $12M to scale rare disease dataset, support drug discovery

The company’s core product is a physician-ordered genetic test for undiagnosed rare disease patients, who typically face a seven-year diagnostic odyssey before getting answers.

Biomarker discovery and patient stratification in pancreatic cancer using incomplete multi-omics data

by Alejandra Paja-García, Rafael Romero-Becerra, Tero Aittokallio, Alberto López Pancreatic ductal adenocarcinoma (PDAC), with a 12% 5-year survival rate, is the most aggressive t...

The End of Guesswork: How Precision Diagnostics and Personal Data Are Transforming Preventative Health in Miami

— For decades, the wellness industry has operated largely on trial and error. Consumers have stacked generic multivitamins, chased the latest superfood trends, and navigated isolat...

Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models

The collaboration pairs the Genialis Supermodel with Inventia Life Science’s RASTRUM 3D cell model platform to test therapeutic hypotheses in models that mirror the tumor biology o...

A framework linking polygenic risk to precision gynecological disease models

Precision medicine has transformed the way clinicians approach some forms of cancer, but for the vast majority of gynecological disorders — from endometriosis and polycystic ovary...

General Medicine banks $120M backed by a16z, Eli Lilly and Mercy Health to build out healthcare storefront

General Medicine, started by the founding team that built PillPack and Amazon Pharmacy, is an online marketplace where customers can search, compare and buy care, see insurance and...

How a Cancer Diagnosis Shaped This VC’s Precision Health Thesis

After a near-miss with her own breast cancer diagnosis, Ariel Ganz co-founded Arben Ventures, a precision health and longevity fund that has backed 83 early-stage startups in three...

An AI drug specialist zeroes in on rare forms of obesity

Superluminal Medicines banked $60 million in funding to support development of a drug designed to work similarly to — but potentially more selectively than — Rhythm Pharmaceuticals...

Innovation in Oncology: The Synergy of New and Old Drugs

Years of joint industry-academic engineering suggest that highly engineered single agents will not be the most effective treatments for solid tumors; the solution will be combining...